Next steps for Hodgkin lymphoma – combining brentuximab vedotin with checkpoint inhibitors
Panel discussion on the treatment of adolescent and young adult lymphoma patients
Catherine Bollard et al.
Panel discussion on new technologies in lymphoma – the applications of circulating tumor DNA
Ash Alizadeh et al.
Panel discussion on immune therapies for lymphoma – CAR T-cell therapy and the question of cure
Anas Younes et al.
Panel discussion on large cell lymphomas: subtypes, patient selection and mutations
Andrew Zelenetz et al.
Current projects at City of Hope: CAR T-cells, vaccines and a novel nuceloside analogue
Panel discussion on T-cell lymphoma: current status of therapy and progress
Elaine Jaffe et al.